Peter Senior

University of Alberta — Canada

Medicine · Health Sciences

54h-index12.8kcitations362works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Management and Research(159), Pancreatic function and diabetes(155), Diabetes Treatment and Management(98), Diabetes and associated disorders(86), Renal Transplantation Outcomes and Treatments(26)

Publications352 total

Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapy
Nature Medicine·2026
A Study Protocol for CommuniT1D : A Customized Virtual Peer Support Program For People Living With Type 1 Diabetes In Canada
2026Open Access
Baseline insulin secretion determines the response to abatacept in Stage 1 type 1 diabetes
2025Open Access
Baseline insulin secretion determines the response to abatacept in Stage 1 type 1 diabetes
2025Open Access
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes
Diabetes·2025Open Access
General Population Screening for Type 1 Diabetes in Canada---CanScreenT1D
Canadian Journal of Diabetes·2025
Postpartum Diabetes Screening and Conversion Rates Among Women Diagnosed With Gestational Diabetes Mellitus Using Standard vs Modified Criteria During the COVID-19 Pandemic
Canadian Journal of Diabetes·2025
Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council
Diabetologia·2025· 2 citedOpen Access
Perceptions of the Benefits and Risks of Novel Therapies for Type 1 Diabetes: A Qualitative Study
Diabetes Therapy·2025Open Access
Risk of Recurrent Hypoglycemia and Long-term Survival after total Pancreatectomy
Annals of Surgery·2025
In insulin-treated T2D, automated insulin delivery reduced HbA<sub>1c</sub> without increasing hypoglycemic events vs. usual care at 13 wk
Annals of Internal Medicine·2025
Sequential islet transplants for type 1 diabetes are not associated with sustained or cumulative increases in hepatic portal venous pressure
PLoS ONE·2025Open Access
1962-LB: Baseline Insulin Secretion Determines the Response to Abatacept In Stage 1 Type 1 Diabetes
Diabetes·2025
Do Provincial Formulary Restrictions Explain Differential Uptake of Sodium-Glucose Cotransporter-2 Inhibitors in Adults With Diabetes and Cardiovascular Disease in Canada? A Retrospective Cohort Study of Pharmacy Claims
Canadian Journal of Diabetes·2025
A microRNA-based dynamic risk score for type 1 diabetes
Nature Medicine·2025· 10 citedOpen Access
Evaluating the feasibility of a co-designed technology-enabled, collaborative care program for young adults with type 1 diabetes and diabetes distress: A protocol
Digital Health·2025Open Access
Modeling Cardiovascular Protection With SGLT Inhibition in Type 1 Diabetes: A Risk-Based Approach to Guide Therapy?
Diabetes Care·2025· 3 citedOpen Access
Use of Medical Identification for People Living With Type 1 Diabetes: Results From the BETTER Registry
Diabetes Care·2025Open Access
Modeling Cardiorenal Protection with Sodium-Glucose Cotransporter 2 Inhibition in Type 1 Diabetes: An Analysis of DEPICT-1 and DEPICT-2
Clinical Journal of the American Society of Nephrology·2025· 6 cited
Glycemic Management Across the Lifespan for People With Type 1 Diabetes: A Clinical Practice Guideline
Canadian Journal of Diabetes·2025· 6 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Edmond A. Ryan(14), A. M. James Shapiro(14), Breay W. Paty(13), A. M. James Shapiro(12), David L. Bigam(11), Sharleen Imes(8), Tatsuya Kin(8), Jonathan R.T. Lakey(7), Michael R. Rickels(6), Rodolfo Alejandro(6), José Oberholzer(6), Peter G. Stock(6), Melena D. Bellin(6), Norman M. Kneteman(5), Bernhard J. Hering(5), Marie‐Christine Vantyghem(5), James F. Markmann(5), Emanuele Di Angelantonio(5), Carmel Moore(5), Matthew R. Walker(5)